Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis (Q739328): Difference between revisions
From MaRDI portal
Set OpenAlex properties. |
Set OpenAlex properties. |
||
| (One intermediate revision by one other user not shown) | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1016/j.jtbi.2015.06.041 / rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W799664256 / rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1016/j.jtbi.2015.06.041 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W799664256 / rank | |||
Normal rank | |||
Latest revision as of 19:02, 19 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis |
scientific article |
Statements
Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis (English)
0 references
18 August 2016
0 references
PKPD modeling
0 references
HCV
0 references
mixture modeling
0 references
